Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program
Open Access
- 1 September 2017
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 37 (9) , 1710-1721
Abstract
Objective—: Molecular pathways governing blood vessel patterning are vital to vertebrate development. Because of their ability to counteract proangiogenic factors, antiangiogenic secreted Sema3 (class 3 semaphorins) control embryonic vascular morphogenesis. However, if and how Sema3 may play a role in the control of extraembryonic vascular development is presently unknown. Approach and Results—: By characterizing genetically modified mice, here, we show that surprisingly Sema3F acts instead as a selective extraembryonic, but not intraembryonic proangiogenic cue. Both in vivo and in vitro, in visceral yolk sac epithelial cells, Sema3F signals to inhibit the phosphorylation-dependent degradation of Myc, a transcription factor that drives the expression of proangiogenic genes, such as the microRNA cluster 17/92. In Sema3f -null yolk sacs, the transcription of Myc-regulated microRNA 17/92 cluster members is impaired, and the synthesis of Myc and microRNA 17/92 foremost antiangiogenic target Thbs1 (thrombospondin 1) is increased, whereas Vegf (vascular endothelial growth factor) signaling is inhibited in yolk sac endothelial cells. Consistently, exogenous recombinant Sema3F inhibits the phosphorylation-dependent degradation of Myc and the synthesis of Thbs1 in mouse F9 teratocarcinoma stem cells that were in vitro differentiated in visceral yolk sac epithelial cells. Sema3f −/− mice placentas are also highly anemic and abnormally vascularized. Conclusions—: Sema3F functions as an unconventional Sema3 that promotes extraembryonic angiogenesis by inhibiting the Myc-regulated synthesis of Thbs1 in visceral yolk sac epithelial cells.Keywords
This publication has 51 references indexed in Scilit:
- Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in CancerCancer Cell, 2012
- Molecular control of endothelial cell behaviour during blood vessel morphogenesisNature Reviews Molecular Cell Biology, 2011
- Targeting the PI3K signaling pathway in cancerCurrent Opinion in Genetics & Development, 2010
- Thrombospondin‐1 modulates vascular endothelial growth factor activity at the receptor levelThe FASEB Journal, 2009
- Mechanotransduction in vascular physiology and atherogenesisNature Reviews Molecular Cell Biology, 2009
- Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesisProceedings of the National Academy of Sciences, 2008
- A C. elegans Myc-like network cooperates with semaphorin and Wnt signaling pathways to control cell migrationDevelopmental Biology, 2007
- Augmentation of tumor angiogenesis by a Myc-activated microRNA clusterNature Genetics, 2006
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995